These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 716006)

  • 1. Effects of hemoperfusion rate and time of initiation of ACAC charcoal hemoperfusion on the survival of fulminant hepatic failure rats.
    Chang TM; Lister C; Chirito E; O'Keefe P; Resurreccion E
    Trans Am Soc Artif Intern Organs; 1978; 24():243-5. PubMed ID: 716006
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparisons of six artificial liver support regimes in fulminant hepatic coma rats.
    Tabata Y; Chang TM
    Trans Am Soc Artif Intern Organs; 1980; 26():394-9. PubMed ID: 7245521
    [No Abstract]   [Full Text] [Related]  

  • 3. Artificial liver: the effect of ACAC microencapsulated charcoal hemoperfusion on fulminant hepatic failure.
    Chirito E; Reiter B; Lister C; Chang TM
    Artif Organs; 1977 Aug; 1(1):76-83. PubMed ID: 616275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of possible toxins in hepatic coma including the removal of mercaptan by albumin-collodion charcoal.
    Chang TM; Lister C
    Int J Artif Organs; 1980 Mar; 3(2):108-12. PubMed ID: 7364505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haemoperfusion through activated carbon adsorbents in liver failure and hepatic coma.
    Bartels O
    Acta Hepatogastroenterol (Stuttg); 1978 Aug; 25(4):324-9. PubMed ID: 696211
    [No Abstract]   [Full Text] [Related]  

  • 6. Acute fulminant hepatic failure. Potential therapeutic role of hemoperfusion.
    Willson RA
    Gastroenterology; 1975 Jul; 69(1):244-8. PubMed ID: 1097291
    [No Abstract]   [Full Text] [Related]  

  • 7. [Achievements in the treatment of acute hepatic insufficiency].
    Kozakiewicz H
    Pol Tyg Lek; 1981 Apr; 36(15):537-9. PubMed ID: 7024943
    [No Abstract]   [Full Text] [Related]  

  • 8. Hemoperfusion in 1981.
    Chang TM
    Contrib Nephrol; 1982; 29():11-22. PubMed ID: 7042197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experiences in the treatment of fulminant hepatic failure by conservative therapy, charcoal haemoperfusion, and polyacrylonitrile haemodialysis.
    Silk DB; Williams R
    Int J Artif Organs; 1978 Jan; 1(1):29-33. PubMed ID: 669832
    [No Abstract]   [Full Text] [Related]  

  • 10. Soluble liver extract as supplement to detoxification by hemoperfusion in liver failure.
    Dixit V; Chang TM
    Int J Artif Organs; 1981 Nov; 4(6):291-4. PubMed ID: 7333688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of parenchymatous hepatic coma using exchange transfusions].
    Kettner W; Hörning I; Strähnz K; Müller D; Oehme G; Fischer G
    Z Arztl Fortbild (Jena); 1971 Sep; 65(18):963-6. PubMed ID: 5151130
    [No Abstract]   [Full Text] [Related]  

  • 12. The effects of hemoperfusion using coated charcoal or tyrosinase artificial cells on middle molecules and tyrosine in brain and serum of hepatic coma rats.
    Shi ZQ; Chang TM
    Trans Am Soc Artif Intern Organs; 1982; 28():205-9. PubMed ID: 6819667
    [No Abstract]   [Full Text] [Related]  

  • 13. A combined charcoal-resin hemoperfusion system in acute experimental hepatic failure in pigs. Depurative activity on plasma amino acids.
    Marrano D; Plicchi G; Liguori L; Marchesini G; Campione O; Spighi M; Roversi CA; Betti V; Vatrella S; Melli A
    Life Support Syst; 1983; 1 Suppl 1():74-7. PubMed ID: 6336465
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hemoperfusion across charcoal in acute hepatic failure in the dog].
    Horák J; Horký J; Rábl M
    Cesk Gastroenterol Vyz; 1980 Mar; 34(2):86-95. PubMed ID: 7388982
    [No Abstract]   [Full Text] [Related]  

  • 15. Experimental artificial liver support with emphasis on fulminant hepatic failure: concepts and review.
    Chang TM
    Semin Liver Dis; 1986 May; 6(2):148-58. PubMed ID: 3529408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical, hematological and histological changes in a fulminant hepatic failure rat model for artificial liver assessment.
    Chirito E; Lister C; Chang TM
    Artif Organs; 1979 Feb; 3(1):42-6. PubMed ID: 435123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of hemoperfusion using coated bead-type charcoal on middle molecules of hepatic failure dogs.
    Nishiki M; Kawanishi H; Kanao M; Sugiyama M; Tsuchiya T; Ezaki H
    Hiroshima J Med Sci; 1984 Sep; 33(3):493-7. PubMed ID: 6511475
    [No Abstract]   [Full Text] [Related]  

  • 18. Influence of hemoperfusion using polyetherurethane sheet embedded with powdered charcoal (UPC) on middle molecules of hepatic failure dogs.
    Kawanishi H; Nishiki M; Kanao M; Nakagawa K; Sugiyama M; Tsuchiya T; Ezaki H
    Hiroshima J Med Sci; 1984 Dec; 33(4):633-8. PubMed ID: 6534919
    [No Abstract]   [Full Text] [Related]  

  • 19. [Variation of serum free amino acids in fulminant hepatitis treated with hepatic assists (author's transl)].
    Tsuji Y; Kondo M; Matsushita M; Koshino I; Kon T; Sawada Y; Kasai Y
    Hokkaido Igaku Zasshi; 1980 Jan; 55(1):59-65. PubMed ID: 7409729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fulminant liver failure: clinical and experimental study.
    Slapak M
    Ann R Coll Surg Engl; 1975 Nov; 57(5):234-47. PubMed ID: 812415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.